@perceiv_ai, une startup basée à Montréal, a développé une plateforme qui utilise l’intelligence artificielle pour anticiper les effets des traitements contre des maladies telles que la maladie d’Alzheimer. https://t.co/dkHADAx49P
Great start of 2024! 🎉 At
@perceiv_ai we are excited to announce a new partnership with @alleolabs to de-risk and support their clinical trials of ALO-001, a potential first-in-class deubiquitinating enzyme inhibitor for treating Parkinson’s and Alzheimer’s disease.
In this StartUp Health Studio interview, Dr. Christian Dansereau shares how his AI-driven precision medicine company, @perceiv_ai, is developing a multimodal prognostic platform to forecast disease progression in age-related disorders. https://t.co/rZH9wV8SWi
🤝 StartUp Health co @perceiv_ai announced a strategic partnership with @alleolabs to help select the most optimal patients for Alleo's upcoming clinical trials of ALO-001 for treating Parkinson’s and Alzheimer’s disease. https://t.co/1iN7jyybYp
🚀 Exciting news at Perceiv AI! 🛡️ We're thrilled to announce HIPAA Compliance, validating our commitment to data security. Join us in reshaping precision medicine with Foresight, our multimodal prognostic platform. 👉 https://t.co/QImxdUDroh
This week’s podcast features two #HealthTransformers—from @pearsuiteinc and @perceiv_ai—who are passionate about helping seniors thrive as they age, from using AI to predict Alzheimer's earlier to empowering front-line community health workers. https://t.co/hBSXGzrIuC
#HealthTransformer@chrisdansereau of @perceiv_ai joined us in the #StartUpHealth Studio @ #HLTH203 to talk about how his company optimizes & de-risks clinical trials for degenerative brain disorders, as well as empowers earlier patient diagnoses & interventions in the clinic.
A big milestone in #Alzheimer's treatment: FDA approves #Leqembi as the 1st disease-modifying therapy for AD, offering new hope to patients & families. @perceiv is working toward a risk predictor of AD's progression that can help better manage patients. https://t.co/uZHYJNnLMg
Bravo à notre partenaire @perceiv_ai qui a joint l'incubateur de premier plan dans le domaine des sciences de la vie, le Johnson & Johnson Innovation @JLABS.
https://t.co/RigteRHnIX